[
  {
    "ts": null,
    "headline": "Stryker wins FDA clearance for minimally invasive back pain treatment",
    "summary": "The company will compete with a device Boston Scientific acquired for $850 million.",
    "url": "https://finnhub.io/api/news?id=6be53814045139a8dab999183bceb2372c6c32bd13e8d312547ec1ec26b93b41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747929536,
      "headline": "Stryker wins FDA clearance for minimally invasive back pain treatment",
      "id": 134658644,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The company will compete with a device Boston Scientific acquired for $850 million.",
      "url": "https://finnhub.io/api/news?id=6be53814045139a8dab999183bceb2372c6c32bd13e8d312547ec1ec26b93b41"
    }
  },
  {
    "ts": null,
    "headline": "Investors in Boston Scientific (NYSE:BSX) have seen splendid returns of 182% over the past five years",
    "summary": "When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...",
    "url": "https://finnhub.io/api/news?id=957e8b396f78a64302bcec826b79c41f90e182c113e9b92b1aa06e6aad5f56cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747911662,
      "headline": "Investors in Boston Scientific (NYSE:BSX) have seen splendid returns of 182% over the past five years",
      "id": 134648014,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...",
      "url": "https://finnhub.io/api/news?id=957e8b396f78a64302bcec826b79c41f90e182c113e9b92b1aa06e6aad5f56cc"
    }
  },
  {
    "ts": null,
    "headline": "Artisan Global Opportunities Fund Q1 2025 Commentary",
    "summary": "The Artisan Global Opportunities Fund portfolio generated negative absolute returns for Q1 of 2025. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=f6d78cb14e7f38f45300260494bcda66c2c15327813613cd55ed2f8b93d5b2a4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747899600,
      "headline": "Artisan Global Opportunities Fund Q1 2025 Commentary",
      "id": 134648301,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2174795498/image_2174795498.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "The Artisan Global Opportunities Fund portfolio generated negative absolute returns for Q1 of 2025. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=f6d78cb14e7f38f45300260494bcda66c2c15327813613cd55ed2f8b93d5b2a4"
    }
  }
]